Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Minority Interest (2009 - 2025)

Grifols' (GIFLF) quarterly Minority Interest came in at $2.7 billion in Q4 2025, down 6.71% on a YoY basis from $2.9 billion in Q4 2024, and down 6.71% quarter-over-quarter from $2.9 billion in Q4 2024.

Analysis

Grifols (GIFLF) Minority Interest (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Minority Interest for 17 consecutive years, with $2.7 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Minority Interest fell 6.71% year-over-year to $2.7 billion; the trailing twelve-month figure through Dec 2025 stood at $2.7 billion (down 6.71% YoY), and the FY2025 full-year result was $2.6 billion, down 9.45% from the prior year.
  • Minority Interest retreated to $2.7 billion in Q4 2025 per GIFLF's latest filing, from $2.9 billion in the prior quarter.
  • Across five years, Minority Interest topped out at $2.9 billion in Q4 2024 and bottomed at $2.1 billion in Q4 2021.
  • Historically, Minority Interest has averaged $2.5 billion across 5 years, with a median of $2.4 billion in 2022.
  • The sharpest annual moves came in 2024 and 2025: Minority Interest gained 26.06% in 2024, then dropped 6.71% in 2025.
  • Over 5 years, Minority Interest stood at $2.1 billion in 2021, then increased by 15.74% to $2.4 billion in 2022, then dropped by 2.8% to $2.3 billion in 2023, then gained by 26.06% to $2.9 billion in 2024, then fell by 6.71% to $2.7 billion in 2025.
  • According to Business Quant data, Minority Interest over the past three periods registered $2.7 billion, $2.9 billion, and $2.3 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.71 Bn
Dec 31, 2024 2.91 Bn
Dec 31, 2023 2.31 Bn
Dec 31, 2022 2.37 Bn
Dec 31, 2021 2.05 Bn
Dec 31, 2020 1.92 Bn
Sep 30, 2020 2.06 Bn
Mar 31, 2020 1.84 Bn
Dec 31, 2019 2.24 Bn
Sep 30, 2019 578.62 Mn
Dec 31, 2018 537.65 Mn
Sep 30, 2018 2.73 Mn
Jun 30, 2018 4.59 Mn
Mar 31, 2018 584.68 Mn
Dec 31, 2017 5.75 Mn
Jun 30, 2017 6.36 Mn
Dec 31, 2016 7.01 Mn
Sep 30, 2016 4.51 Mn
Jun 30, 2016 4.69 Mn
Dec 31, 2015 5.69 Mn